TEARLAB CORPORATION

Ajouter à une liste

Instrument Inactif

Communiqués TearLab Corporation

Actions

Equipement, fournitures et distribution médicale

Communiqués

09/07/20	TEARLAB CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
26/06/20	TearLab: 1Q Earnings Snapshot	AQ
26/06/20	TEARLAB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	AQ
08/06/20	TEARLAB : Entry into a Material Definitive Agreement (form 8-K/A)	AQ
29/05/20	TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)	AQ
13/05/20	TEARLAB CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
12/05/20	TEARLAB CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
11/05/20	TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
11/05/20	TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/05/20	TearLab : Announces Acquisition By Accelmed Partners And Related $25 Million Investment	PR
07/05/20	TEARLAB CORP : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
07/05/20	TearLab Corporation Confirms Merger Discussions	GL
22/04/20	TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test	GL
21/04/20	TEARLAB CORP : Change in Directors or Principal Officers, Other Events (form 8-K)	AQ
07/04/20	TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)	AQ
06/03/20	TEARLAB : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
05/03/20	TearLab: 4Q Earnings Snapshot	AQ
05/03/20	TEARLAB CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	AQ
05/03/20	TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT

🔇